Open-Label Study of OTO-201 for Treatment of AOMT
NCT02408796
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Otitis Media
AOMT
Interventions
DRUG:
OTO-201
Sponsor
Otonomy, Inc.